# ADC Therapeutics SA (ADCT) ADC Therapeutics SA's social dominance has surged, with creators and posts up significantly week-over-week. The company's Galaxy Score hit a 52-week and all-time high, indicating strong recent social engagement. ### About ADC Therapeutics SA ADC Therapeutics SA is a clinical-stage biotechnology company focused on developing and commercializing antibody-drug conjugates for cancer treatment. ADC Therapeutics SA uses the ticker $ADCT for trading. Listed in the [Stocks](/list/stocks) category. ### Insights - ADC Therapeutics SA (ADCT) social dominance hit [------] which is 153% higher than it's daily average. - ADC Therapeutics SA (ADCT) social dominance is up 255.79% from the previous week. - ADC Therapeutics SA (ADCT) creators is up 16.67% from the previous week. - ADC Therapeutics SA (ADCT) posts created is up 168.75% from the previous week. - ADC Therapeutics SA Galaxy Score™ hit a 52-Week high of [--] for the hour - ADC Therapeutics SA Galaxy Score™ hit an all time of [--] for the hour - ADC Therapeutics SA entered the top [--] AltRank™ for the first time in [--] days ### Price: $4  [Price 24-Hour Time-Series Raw Data](/topic/$adct/time-series/close.tsv) The stock price is under downward pressure due to negative reactions to the LOTIS-7 trial data, which has reversed recent highs. Social media sentiment is mixed, with critical themes around decreased recent activity potentially contributing to the negative price action. 24-Hour: -0.75% 7-Day: -0.5% 30-Day: 10.22% 1-Year High: $4.60 on 2025-10-30 1-Year Low: $2.60 on 2025-08-06 ### AltRank: [-----]  [AltRank 24-Hour Time-Series Raw Data](/topic/$adct/time-series/alt_rank.tsv) ADC Therapeutics SA (ADCT) is currently AltRank #1,757 based on combined combined social and market metrics Daily Average: [-----] [--] Week: [-----] +966 [--] Month: [-----] +229 1-Year High: [-----] on 2026-02-11 1-Year Low: [--] on 2026-01-17 ### Galaxy Score: [-----]  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$adct/time-series/galaxy_score.tsv) Current Value: [-----] Daily Average: [--] [--] Week: [--] [---] [--] Month: [--] [---] [--] Months: [--] [---] [--] Year: [--] [---] 1-Year High: [--] on 2026-02-04 1-Year Low: [--] on 2026-01-30 ### Engagements: [-----] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$adct/time-series/interactions.tsv) Current Value: [-----] Daily Average: [-----] [--] Week: [-----] -9.30% [--] Month: [------] +6.80% [--] Months: [-------] -87% [--] Year: [---------] +25% 1-Year High: [-------] on 2025-06-11 1-Year Low: [--] on 2025-04-20 Engagements by network (24h): X: [---] Reddit: [--] ### Mentions: [--] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$adct/time-series/posts_active.tsv) Current Value: [--] Daily Average: [--] [--] Week: [---] +5.40% [--] Month: [---] +13% [--] Months: [---] -19% [--] Year: [-----] +156% 1-Year High: [---] on 2025-06-28 1-Year Low: [--] on 2025-02-16 Mentions by network (24h): X: [--] Reddit: [--] ### Creators: [--] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$adct/time-series/contributors_active.tsv) [--] unique social accounts have posts mentioning ADC Therapeutics SA (ADCT) in the last [--] hours which is down 12% from [--] in the previous [--] hours Daily Average: [--] [--] Week: [--] +17% [--] Month: [---] -3.80% [--] Months: [---] -55% [--] Year: [-----] +209% 1-Year High: [---] on 2025-06-28 1-Year Low: [--] on 2025-02-16 ### Sentiment: 10%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$adct/time-series/sentiment.tsv) Current Value: 10% Daily Average: 67% [--] Week: 33% -67% [--] Month: 10% -20% [--] Months: 10% -90% [--] Year: 10% -90% 1-Year High: 100% on 2025-02-15 1-Year Low: 4% on 2025-12-14 Most Supportive Themes: - Clinical Trial Progress: (40%) ADC Therapeutics SA is a biotechnology company focused on developing and commercializing novel antibody-drug conjugates (ADCs) for the treatment of cancer. - M&A Activity Speculation: (30%) ADC Therapeutics SA is a biotechnology company focused on developing and commercializing novel antibody-drug conjugates (ADCs) for the treatment of cancer. Most Critical Themes: - Decreased Recent Activity: (30%) ADC Therapeutics SA is a biotechnology company focused on developing and commercializing novel antibody-drug conjugates (ADCs) for the treatment of cancer. ### Social Dominance: 0.00649%  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$adct/time-series/social_dominance.tsv) Current Value: 0.00649% Daily Average: 0.00423% [--] Week: 0.00676% +0.00486% [--] Month: 0.011% -0.0027% [--] Months: 0.011% +0.0082% [--] Year: 0.011% +0.0091% 1-Year High: 0.033% on 2025-06-29 1-Year Low: 0.0002% on 2025-02-16 ### Market Dominance: 0.0005597403956961%  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$adct/time-series/market_dominance.tsv) Current Value: 0.0005597403956961% Daily Average: 0% 1-Year High: 0.023% on 2026-02-06 1-Year Low: 0.00056% on 2026-02-14 ### Market Cap: $494,269,673  [Market Cap 24-Hour Time-Series Raw Data](/topic/$adct/time-series/market_cap.tsv) Current Value: $494,269,673 Daily Average: $475,365,204 [--] Week: $494,269,673 -0.50% [--] Month: $494,269,673 +12% 1-Year High: $569,834,711 on 2025-12-02 1-Year Low: $398,884,297 on 2025-12-08 Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
ADC Therapeutics SA's social dominance has surged, with creators and posts up significantly week-over-week. The company's Galaxy Score hit a 52-week and all-time high, indicating strong recent social engagement.
ADC Therapeutics SA is a clinical-stage biotechnology company focused on developing and commercializing antibody-drug conjugates for cancer treatment.
ADC Therapeutics SA uses the ticker $ADCT for trading. Listed in the Stocks category.
Price 24-Hour Time-Series Raw Data
The stock price is under downward pressure due to negative reactions to the LOTIS-7 trial data, which has reversed recent highs. Social media sentiment is mixed, with critical themes around decreased recent activity potentially contributing to the negative price action.
24-Hour: -0.75% 7-Day: -0.5% 30-Day: 10.22%
1-Year High: $4.60 on 2025-10-30
1-Year Low: $2.60 on 2025-08-06
AltRank 24-Hour Time-Series Raw Data
ADC Therapeutics SA (ADCT) is currently AltRank #1,757 based on combined combined social and market metrics
Daily Average: [-----]
[--] Week: [-----] +966
[--] Month: [-----] +229
1-Year High: [-----] on 2026-02-11
1-Year Low: [--] on 2026-01-17
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2026-02-04
1-Year Low: [--] on 2026-01-30
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [-----] -9.30%
[--] Month: [------] +6.80%
[--] Months: [-------] -87%
[--] Year: [---------] +25%
1-Year High: [-------] on 2025-06-11
1-Year Low: [--] on 2025-04-20
Engagements by network (24h): X: [---] Reddit: [--]
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +5.40%
[--] Month: [---] +13%
[--] Months: [---] -19%
[--] Year: [-----] +156%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-02-16
Mentions by network (24h): X: [--] Reddit: [--]
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning ADC Therapeutics SA (ADCT) in the last [--] hours which is down 12% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [--] +17%
[--] Month: [---] -3.80%
[--] Months: [---] -55%
[--] Year: [-----] +209%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-02-16
Sentiment 24-Hour Time-Series Raw Data
Current Value: 10%
Daily Average: 67%
[--] Week: 33% -67%
[--] Month: 10% -20%
[--] Months: 10% -90%
[--] Year: 10% -90%
1-Year High: 100% on 2025-02-15
1-Year Low: 4% on 2025-12-14
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00649%
Daily Average: 0.00423%
[--] Week: 0.00676% +0.00486%
[--] Month: 0.011% -0.0027%
[--] Months: 0.011% +0.0082%
[--] Year: 0.011% +0.0091%
1-Year High: 0.033% on 2025-06-29
1-Year Low: 0.0002% on 2025-02-16
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0005597403956961%
Daily Average: 0%
1-Year High: 0.023% on 2026-02-06
1-Year Low: 0.00056% on 2026-02-14
Market Cap 24-Hour Time-Series Raw Data
Current Value: $494,269,673
Daily Average: $475,365,204
[--] Week: $494,269,673 -0.50%
[--] Month: $494,269,673 +12%
1-Year High: $569,834,711 on 2025-12-02
1-Year Low: $398,884,297 on 2025-12-08
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$adct